Which diagnoses are considered early atherosclerotic cardiovascular disease (ASCVD)?

Early Atherosclerotic Cardiovascular Disease (ASCVD): Defining Diagnoses

Early ASCVD encompasses atherosclerotic cardiovascular events occurring in men aged ≤55 years and women aged ≤65 years, including ischemic heart disease, ischemic stroke, and peripheral arterial disease. 1, 2

Core Diagnostic Categories

Early or premature ASCVD includes three primary manifestations:

• Ischemic Heart Disease (IHD): Myocardial infarction, acute coronary syndrome, or coronary artery disease requiring revascularization
• Ischemic Cerebrovascular Disease: Ischemic stroke or transient ischemic attack
• Peripheral Arterial Disease (PAD): Symptomatic claudication with ankle-brachial index <0.85, or history of revascularization/amputation

3, 1, 2

Age Thresholds for "Early" Classification

The definition is sex-specific based on typical age of ASCVD onset:

• Men: Events occurring at age ≤55 years
• Women: Events occurring at age ≤65 years

This 10-year difference reflects the protective effect of estrogen in premenopausal women. 1, 2

Subclinical Atherosclerosis as Early Disease

Coronary artery calcium (CAC) score >0 confirms the presence of atherosclerotic plaque and represents early subclinical ASCVD, even in asymptomatic individuals. 4 The presence of atherosclerosis on imaging—whether coronary calcium, carotid plaque, or ankle-brachial index <0.9—indicates established disease requiring aggressive risk factor modification regardless of symptom status. 3, 5

CAC Score Interpretation:

• CAC = 0: Very high negative predictive value (95-99%) for near-term events, though not zero risk
• CAC >0: Confirms atherosclerotic plaque presence
• CAC >100: High risk (>2% annual event risk), warrants intensive treatment
• CAC >300: Very high risk (~28% 10-year MI/CV death risk)

4, 6

Risk-Enhancing Conditions That Signal Early ASCVD Risk

Several conditions identify individuals at elevated risk for developing early ASCVD, even before clinical events:

Genetic/Familial Factors:

• Familial hypercholesterolemia (heterozygous or homozygous)
• Family history of premature ASCVD (first-degree male relative <55 years, female relative <65 years)
• Elevated lipoprotein(a) ≥50 mg/dL or ≥125 nmol/L

3, 4, 7

Metabolic Conditions:

• Diabetes mellitus (particularly early-onset)
• Metabolic syndrome
• Chronic kidney disease (eGFR 15-59 mL/min/1.73 m²)
• Persistently elevated LDL-C (≥160 mg/dL or ≥4.1 mmol/L)

3, 6

Inflammatory/Autoimmune States:

• Rheumatoid arthritis
• Systemic lupus erythematosus
• Psoriasis
• HIV/AIDS

3, 8

Women-Specific Risk Factors:

• Premature menopause (before age 40)
• Preeclampsia
• Gestational diabetes
• Preterm delivery

3, 8

Lifestyle/Substance Use:

• Current smoking
• Substance abuse (cocaine, methamphetamine)

1, 2

Clinical Implications

The critical distinction is that early ASCVD represents disease occurring at younger ages when lifetime exposure to risk factors has been shorter, suggesting either more aggressive risk factor burden, genetic predisposition, or unique accelerating factors. 2 These patients face substantially more disability-adjusted life years lost and require particularly aggressive primary and secondary prevention strategies.

Common Pitfalls:

• Don't dismiss young patients with chest pain—early ASCVD is increasing globally, particularly in lower socioeconomic regions 9
• CAC = 0 doesn't mean zero risk in high-risk young patients with diabetes, smoking, familial hypercholesterolemia, or strong family history 4
• Women and Black individuals disproportionately present with death/cardiac arrest as first manifestation of ASCVD 10

The growing burden of early ASCVD, driven by increasing obesity, diabetes, and metabolic syndrome in younger populations, makes identification and aggressive management of these conditions imperative for preventing premature cardiovascular events. 9, 2